drugset / Trial / NCT00798460
Efficacy of Clevudine Plus Lamivudine for Lamivudine-resistant Chronic Hepatitis B Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the optimal antiviral treatment for lamivudine resistant hepatitis B patients.
Timeline
- Start
- 2008-12
- Primary completion
- 2010-06
- Completion
- 2010-11
Outcome
Outcome not reported
Stopped (Enrollment): “could not enroll patients”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Clevudine | Small molecule | 30 mg | — |
| Comparator | Lamivudine | Other / unclassified | 100 mg | — |
| Comparator | Adefovir | Unknown | 10 mg | — |